Colin R. Mallet
Direttore/Membro del Consiglio presso MedGenesis Therapeutix, Inc.
Profilo
Colin R.
Mallet is currently a Director at MedGenesis Therapeutix, Inc. and Clean Current Power Systems, Inc. He previously served as President & CEO at Sandoz Canada, Inc. and Chairman at Canada's Research Based Pharmaceutical Cos.
He also held director positions at Aptalis Pharma Canada ULC, AnorMED, Inc., Isotechnika, Inc., MIGENIX, Inc., Mirati Therapeutics, Inc., Intrinsic Therapeutics, Inc., and Isotechnika Pharma, Inc. Mr. Mallet completed his undergraduate degree at the University of Cambridge.
Posizioni attive di Colin R. Mallet
| Società | Posizione | Inizio |
|---|---|---|
MedGenesis Therapeutix, Inc.
 MedGenesis Therapeutix, Inc. Medical SpecialtiesHealth Technology MedGenesis Therapeutix, Inc. provides diagnostic product services. The private company is based in Victoria, Canada. The Canadian company was founded by Erich Mohr, Howard J. Federoff. Erich Mohr has been the CEO since incorporation. | Direttore/Membro del Consiglio | - |
Clean Current Power Systems, Inc.
 Clean Current Power Systems, Inc. Electric UtilitiesUtilities Clean Current Power Systems, Inc. operates as a renewable energy technology services. It provides technologies which includes river turbines, tidal turbines, generators, marine coatings and operational control systems. The company was founded by Emmanuel J. Grillos, Christopher Gora and John Greiner in 2001 and is headquartered in Vancouver, Canada. | Direttore/Membro del Consiglio | 29/09/2011 |
Precedenti posizioni note di Colin R. Mallet
| Società | Posizione | Fine |
|---|---|---|
| MIRATI THERAPEUTICS | Direttore/Membro del Consiglio | 12/11/2012 |
MIGENIX, Inc.
 MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Direttore/Membro del Consiglio | 11/08/2008 |
Intrinsic Therapeutics, Inc.
 Intrinsic Therapeutics, Inc. Medical SpecialtiesHealth Technology Intrinsic Therapeutics, Inc. develops device-based therapies for soft-tissue injuries of the spine. It offers surgeons and patients better options for treating painful disc herniations that cause sciatica and low back pain. The company was founded by Gregory H. Lambrecht in 1999 and is headquartered in Woburn, MA. | Direttore/Membro del Consiglio | - |
Isotechnika Pharma, Inc.
 Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Direttore/Membro del Consiglio | - |
AnorMED, Inc.
 AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | Direttore/Membro del Consiglio | - |
Formazione di Colin R. Mallet
| University of Cambridge | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Aptalis Pharma Canada ULC
 Aptalis Pharma Canada ULC Pharmaceuticals: MajorHealth Technology Aptalis Pharma Canada ULC provided pharmaceutical products. The company was founded in 1982 and was headquartered in Mount Saint-Hilaire, Canada. | Health Technology |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
MedGenesis Therapeutix, Inc.
MedGenesis Therapeutix, Inc. Medical SpecialtiesHealth Technology MedGenesis Therapeutix, Inc. provides diagnostic product services. The private company is based in Victoria, Canada. The Canadian company was founded by Erich Mohr, Howard J. Federoff. Erich Mohr has been the CEO since incorporation. | Health Technology |
Isotechnika, Inc.
 Isotechnika, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika, Inc. operates as an international biopharmaceutical company. The firm discovers and develops immunosuppressive therapeutic drugs for treatment of autoimmune diseases and for use in the prevention of organ rejection in transplantation. The company is headquartered in Edmonton, Canada. | Health Technology |
Sandoz Canada, Inc.
 Sandoz Canada, Inc. Pharmaceuticals: MajorHealth Technology Sandoz Canada, Inc. develops, manufactures, and distributes injections and ophthalmic pharmaceutical products for the hospital and retail markets. It offers ampoules, vials ophthalmic solutions, suspensions and ointments, and suppositories. The company was founded in 1973 and is headquartered in Boucherville, Canada. | Health Technology |
| Canada's Research Based Pharmaceutical Cos. | |
AnorMED, Inc.
AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | Health Technology |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Health Technology |
Clean Current Power Systems, Inc.
Clean Current Power Systems, Inc. Electric UtilitiesUtilities Clean Current Power Systems, Inc. operates as a renewable energy technology services. It provides technologies which includes river turbines, tidal turbines, generators, marine coatings and operational control systems. The company was founded by Emmanuel J. Grillos, Christopher Gora and John Greiner in 2001 and is headquartered in Vancouver, Canada. | Utilities |
Intrinsic Therapeutics, Inc.
Intrinsic Therapeutics, Inc. Medical SpecialtiesHealth Technology Intrinsic Therapeutics, Inc. develops device-based therapies for soft-tissue injuries of the spine. It offers surgeons and patients better options for treating painful disc herniations that cause sciatica and low back pain. The company was founded by Gregory H. Lambrecht in 1999 and is headquartered in Woburn, MA. | Health Technology |
- Borsa valori
- Insiders
- Colin R. Mallet
